BLFS - BioLife Solutions, Inc.
NASDAQ
->
Healthcare
->
Medical Instruments & Supplies
Bothell,
United States
Type: Equity
BLFS price evolution
BLFS
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $35.44 | $19.27 | $21.43 | $19.14 |
| Short term investments | $16.29 | $21.79 | $24.86 | $35.78 |
| Net receivables | $18.66 | $24.56 | $26.86 | $30.34 |
| Inventory | $43.46 | $43.35 | $39.18 | $41.33 |
| Total current assets | $120.6 | $116.82 | $120.31 | $132.79 |
| Long term investments | $5.62 | $6.22 | $6.91 | $7.09 |
| Property, plant & equipment | $40.33 | $40.98 | $51.72 | $50.94 |
| Goodwill & intangible assets | $245.89 | $246.81 | $253.92 | $255.37 |
| Total noncurrent assets | $292.11 | $294.33 | $312.87 | $313.68 |
| Total investments | $21.91 | $28.02 | $31.77 | $42.87 |
| Total assets | $412.71 | $411.15 | $433.18 | $446.47 |
| Current liabilities | ||||
| Accounts payable | $6.94 | $11.98 | $10.69 | $15.53 |
| Deferred revenue | ||||
| Short long term debt | $10.01 | $8.34 | $5.28 | $4.32 |
| Total current liabilities | $42.18 | $42.62 | $39.59 | $47.32 |
| Long term debt | $32.69 | $35.86 | $39.29 | $38.9 |
| Total noncurrent liabilities | $32.87 | $36.51 | $41.46 | $41.04 |
| Total debt | $42.69 | $44.2 | $44.57 | $43.22 |
| Total liabilities | $75.05 | $79.14 | $81.05 | $88.36 |
| Shareholders' equity | ||||
| Retained earnings | -$313.34 | -$299.96 | -$270.83 | -$260.63 |
| Other shareholder equity | -$0.34 | -$0.66 | -$0.5 | -$0.53 |
| Total shareholder equity | $337.66 | $332.02 | $352.13 | $358.11 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $35.44 | $19.47 | $69.87 | $90.46 |
| Short term investments | $16.29 | $43.26 | ||
| Net receivables | $18.66 | $33.94 | $23.22 | $8.01 |
| Inventory | $43.46 | $34.9 | $28.34 | $11.6 |
| Total current assets | $120.6 | $138.45 | $125.86 | $114.71 |
| Long term investments | $5.62 | $6.4 | $4.37 | $5.87 |
| Property, plant & equipment | $40.33 | $48.27 | $46.61 | $24.52 |
| Goodwill & intangible assets | $245.89 | $256.83 | $376.89 | $89.5 |
| Total noncurrent assets | $292.11 | $311.78 | $428.2 | $120.12 |
| Total investments | $21.91 | $49.66 | $4.37 | $5.87 |
| Total assets | $412.71 | $450.23 | $554.06 | $234.83 |
| Current liabilities | ||||
| Accounts payable | $6.94 | $15.37 | $14.95 | $3.67 |
| Deferred revenue | ||||
| Short long term debt | $10.01 | $4.83 | $3.77 | $1.11 |
| Total current liabilities | $42.18 | $44.58 | $40.38 | $15.57 |
| Long term debt | $32.69 | $23.92 | $23.11 | $8.77 |
| Total noncurrent liabilities | $32.87 | $41.46 | $33.54 | $14.01 |
| Total debt | $42.69 | $43.71 | $26.88 | $9.88 |
| Total liabilities | $75.05 | $86.04 | $73.92 | $29.58 |
| Shareholders' equity | ||||
| Retained earnings | -$313.34 | -$246.91 | -$105.02 | -$97.39 |
| Other shareholder equity | -$0.34 | -$0.68 | -$0.28 | |
| Total shareholder equity | $337.66 | $364.19 | $480.14 | $205.25 |
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $32.73 | $39.51 | $37.7 | |
| Cost of revenue | $23.48 | $27.7 | $23.66 | |
| Gross Profit | $9.25 | $11.81 | $14.04 | |
| Operating activities | ||||
| Research & development | $4.4 | $4.84 | $4.15 | |
| Selling, general & administrative | $17.51 | $21.72 | $21.31 | |
| Total operating expenses | $22.82 | $28.01 | $26.92 | |
| Operating income | -$13.57 | -$16.2 | -$12.88 | |
| Income from continuing operations | ||||
| EBIT | -$12.92 | -$9.78 | -$13.21 | |
| Income tax expense | -$0.04 | $0.01 | $0.09 | |
| Interest expense | $0.51 | $0.42 | $0.41 | |
| Net income | ||||
| Net income | -$13.38 | -$10.2 | -$13.71 | |
| Income (for common shares) | -$13.38 | -$10.2 | -$13.71 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $143.27 | $161.76 | $48.09 | |
| Cost of revenue | $96.52 | $107.94 | $20.65 | |
| Gross Profit | $46.75 | $53.82 | $27.44 | |
| Operating activities | ||||
| Research & development | $18.8 | $14.8 | $6.72 | |
| Selling, general & administrative | $80.31 | $69.24 | $21.02 | |
| Total operating expenses | $119.77 | $204.12 | $31.44 | |
| Operating income | -$73.02 | -$150.29 | -$4 | |
| Income from continuing operations | ||||
| EBIT | -$64.45 | -$144.14 | -$0.66 | |
| Income tax expense | $0.17 | -$5.02 | -$3.26 | |
| Interest expense | $1.81 | $0.69 | -$0.06 | |
| Net income | ||||
| Net income | -$66.43 | -$139.81 | $2.67 | |
| Income (for common shares) | -$66.43 | -$139.81 | $2.67 | |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$13.38 | -$29.13 | -$10.2 | -$13.71 |
| Operating activities | ||||
| Depreciation | $2.29 | $3.74 | $3.06 | $3.6 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $8.33 | $9.12 | $6.86 | $7.36 |
| Total cash flows from operations | $2.31 | -$4.38 | -$7.72 | -$2.71 |
| Investing activities | ||||
| Capital expenditures | -$2.38 | -$2.4 | -$2.16 | -$4.3 |
| Investments | $6.34 | $4.06 | $11.45 | $7.22 |
| Total cash flows from investing | $3.96 | $1.66 | $9.29 | $2.93 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $10.38 | $0.06 | $0.18 | $0.13 |
| Net borrowings | -$0.53 | $0.45 | $0.55 | -$0.7 |
| Total cash flows from financing | $9.84 | $0.61 | $0.7 | -$0.56 |
| Effect of exchange rate | $0.06 | -$0.06 | $0.02 | $0.01 |
| Change in cash and equivalents | $16.11 | -$2.11 | $2.28 | -$0.35 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$66.43 | -$139.81 | -$7.63 | $2.67 |
| Operating activities | ||||
| Depreciation | $12.7 | $19.96 | $14.92 | $5.8 |
| Business acquisitions & disposals | $1.56 | -$16.94 | ||
| Stock-based compensation | $31.67 | $25.33 | $13.96 | $6.04 |
| Total cash flows from operations | -$12.5 | -$8.49 | -$4.59 | $6.64 |
| Investing activities | ||||
| Capital expenditures | -$11.24 | -$13.92 | -$14.75 | -$7.77 |
| Investments | $29.07 | -$44.2 | ||
| Total cash flows from investing | $17.84 | -$58.12 | -$13.19 | -$24.71 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $10.75 | $0.32 | $1.42 | $101.63 |
| Net borrowings | -$0.22 | $16.46 | -$3.93 | $0.98 |
| Total cash flows from financing | $10.59 | $16.32 | -$2.78 | $102.08 |
| Effect of exchange rate | $0.04 | -$0.11 | -$0.02 | |
| Change in cash and equivalents | $15.93 | -$50.29 | -$20.56 | $84.01 |
News
Fundamentals
| Market cap | $761.52M |
|---|---|
| Enterprise value | $768.77M |
| Shares outstanding | 45.17M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | -26.04% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 2.25 |
| Book/Share | 7.48 |
| Cash/Share | 0.78 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.22 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.86 |
| Quick ratio | 1.83 |